LIGAND PHARMACEUTICALS INC ($LGND)
Reardon Andrew โ CLO & Secretary
Shares
4,083
Price
$183.83
Total Value
$750,577.89
Nearby Earnings
Feb 26, 2026
EPS:Est: 1.46
Revenue:Est: $55.59M
Transaction Details
| Insider | Reardon Andrew |
|---|---|
| Title | CLO & Secretary |
| Transaction Date | Feb 14, 2026 |
| Transaction Code | F Tax Withholding |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 14, 2026 |
| Shares Purchased | 4,083 |
| Price per Share | $183.83 |
| Total Value | $750,577.89 |
| Shares Owned After | 39,255 |
| Derivative | No |
| Accession Number | 0002001011-26-000013 |
| Document | View SEC Filing |